Transcriptome sequencing and bioinformatics analysis demonstrated that CCND2 mRNA expression differed significantly in ABC-DLBCL specimens from patients treated with R-CHOP according to differing prognosis in the early stage of our research group. Here, DDIT3 is linked to diffuse large B-cell lymphoma.